B. Weigelt, J. L. Peterse, and L. J. Van't-veer, Breast cancer metastasis: markers and models, Nat Rev Cancer, vol.5, pp.591-602, 2005.

M. R. Junttila and F. J. De-sauvage, Influence of tumour micro-environment heterogeneity on therapeutic response, Nature, vol.501, pp.346-54, 2013.

A. Turtoi, E. De-pauw, and V. Castronovo, Innovative proteomics for the discovery of systemically accessible cancer biomarkers suitable for imaging and targeted therapies, Am J Pathol, vol.178, pp.12-20, 2011.

A. Turtoi, B. Dumont, and Y. Greffe, Novel comprehensive approach for accessible biomarker identification and absolute quantification from precious human tissues, J Proteome Res, vol.10, pp.3160-82, 2011.

B. Dumont, V. Castronovo, and O. Peulen, Differential proteomic analysis of a human breast tumor and its matched bone metastasis identifies cell membrane and extracellular proteins associated with bone metastasis, J Proteome Res, vol.11, pp.2247-60, 2012.

R. Merline, R. M. Schaefer, and L. Schaefer, The matricellular functions of small leucine-rich proteoglycans (SLRPs), J Cell Commun Signal, vol.3, pp.323-358, 2009.

I. Kou, M. Nakajima, and S. Ikegawa, Expression and regulation of the osteoarthritis-associated protein asporin, J Biol Chem, vol.282, pp.32193-32202, 2007.

P. Maris, A. Blomme, and A. P. Palacios, Asporin is a fibroblast-derived TGF-?1 inhibitor and a tumor suppressor associated with good prognosis in breast cancer, PLoS Med, vol.12, p.1001871, 2015.

C. Moyret-lalle, R. Pommier, and C. Bouard, Plasticité des cellules cancéreuses et dissémination métastatique, Med Sci (Paris), vol.32, pp.725-756, 2016.

R. Giavazzi, A. Garofalo, and M. R. Bani, Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice, Cancer Res, vol.50, pp.4771-4776, 1990.

J. R. Reed, R. P. Leon, M. K. Hall, and K. L. Schwertfeger, Interleukin-1beta and fibroblast growth factor receptor 1 cooperate to induce cyclooxygenase-2 during early mammary tumourigenesis, Breast Cancer Res, vol.11, p.21, 2009.

D. S. Hong, D. Hui, and E. Bruera, MABp1, a first-inclass true human antibody targeting interleukin-1? in refractory cancers: an open-label, phase 1 doseescalation and expansion study, Lancet Oncol, vol.15, pp.656-66, 2014.

B. C. Özdemir, T. Pentcheva-hoang, and J. L. Carstens, Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival, Cancer Cell, vol.25, pp.719-753, 2014.